LPL Financial LLC Grows Position in First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH)

LPL Financial LLC increased its position in First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) by 9.3% during the 4th quarter, Holdings Channel reports. The institutional investor owned 55,876 shares of the company’s stock after purchasing an additional 4,776 shares during the period. LPL Financial LLC owned approximately 0.11% of First Trust Nasdaq Pharmaceuticals ETF worth $1,507,000 at the end of the most recent quarter.

First Trust Nasdaq Pharmaceuticals ETF Trading Up 1.5 %

FTXH stock opened at $24.36 on Friday. The stock has a market capitalization of $13.40 million, a price-to-earnings ratio of 17.94 and a beta of 0.70. The firm’s 50-day moving average price is $26.99 and its two-hundred day moving average price is $27.55. First Trust Nasdaq Pharmaceuticals ETF has a 12-month low of $23.29 and a 12-month high of $29.72.

First Trust Nasdaq Pharmaceuticals ETF Cuts Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, March 31st. Investors of record on Thursday, March 27th were issued a dividend of $0.0992 per share. The ex-dividend date of this dividend was Thursday, March 27th. This represents a $0.40 dividend on an annualized basis and a yield of 1.63%.

First Trust Nasdaq Pharmaceuticals ETF Company Profile

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.